ArticleInternational journal of clinical oncology2025
Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
Hiroyuki Kodama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.